82 FR 27848 - Center for Scientific Review; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 82, Issue 116 (June 19, 2017)
National Institutes of Health
Federal Register Volume 82, Issue 116 (June 19, 2017)
| Page Range | 27848-27849 | |
| FR Document | 2017-12591 |
[Federal Register Volume 82, Number 116 (Monday, June 19, 2017)] [Notices] [Pages 27848-27849] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-12591] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Revision Applications for U.S.-South Africa Program for Collaborative Biomedical Research. Date: June 29, 2017. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Robert Freund, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, 301-435- 1050, [email protected]. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: AIDS and Related Research Integrated Review Group; AIDS Molecular and Cellular Biology Study Section. Date: July 10, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5214, MSC 7852, Bethesda, MD 20892, (301) 435-1166, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; AIDS and Related Research Member Conflict. Date: July 10, 2017. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Shalanda A. Bynum, Ph.D., MPH, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3206, Bethesda, MD 20892, 301- 755-4355, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR 16-257: Predicting Behavioral Responses to Population Level Cancer Control Strategies (R21). Date: July 11, 2017. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Karin F. Helmers, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD 20892, (301) 254-9975, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR 15-287: Opportunities for Collaborative Research at the NIH Clinical Center. Date: July 11, 2017. Time: 1:30 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Fungai Chanetsa, MPH, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of [[Page 27849]] Health, 6701 Rockledge Drive, Room 3135, MSC 7770, Bethesda, MD 20892, 301-408-9436, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Digestive Sciences. Date: July 12, 2017. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Martha Garcia, Ph.D., Scientific Reviewer Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2186, MSC 7818, Bethesda, MD 20892, 301-435-1243, [email protected]. Name of Committee: AIDS and Related Research Integrated Review Group; AIDS Immunology and Pathogenesis Study Section. Date: July 12, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Long Beach, 500 East First Street, Long Beach, CA 90802. Contact Person: Shiv A. Prasad, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD 20892, 301-443-5779, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Biological Chemistry and Macromolecular Biophysics. Date: July 12-13, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sergei Ruvinov, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4158, MSC 7806, Bethesda, MD 20892, 301-435-1180, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Urology and Urogynecology Small Business Applications. Date: July 12, 2017. Time: 9:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Ganesan Ramesh, Ph.D., Center for Scientific Review, National Institutes of Health, 6701 Rockledge Dr., Room 2182, MSC 7818, Bethesda, MD 20892, 301-827-5467, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Chemical Discovery for Substance Use Disorders. Date: July 12, 2017. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Michael Eissenstat, Ph.D., Scientific Review Officer, BCMB IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4166, Bethesda, MD 20892, 301- 435-1722, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Molecular Genetics. Date: July 12, 2017. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Methode Bacanamwo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301- 827-7088, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR-16-390: NIBIB Trailblazer Award for New and Early Stage Investigators (R21). Date: July 12-13, 2017. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Chee Lim, Ph.D., Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Room 4128, Bethesda, MD 20892, 301-435-1850, [email protected]. Name of Committee: Center for Scientific Review Special Emphasis Panel; Radiation Therapy and Biology. Date: July 13-14, 2017. Time: 9:00 a.m. to 11:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Bo Hong, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6194, MSC 7804, Bethesda, MD 20892, 301-996- 6208, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: June 13, 2017. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017-12591 Filed 6-16-17; 8:45 am] BILLING CODE 4140-01-P
![27848 Federal Register / Vol. 82, No. 116 / Monday, June 19, 2017 / Notices
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued
Number of
Number of Total annual Average burden
Activity responses per Total hours 2
respondents responses per response
respondent
Total ................................................................... ........................ ........................ ........................ ................................... 845
1 Thereare no capital costs or operating and maintenance costs associated with this collection of information.
2 Rounded to the next full hour.
II. References Drug Administration’s Bad Ad Program Name of Committee: AIDS and Related
and Education Regarding Pharmaceutical Research Integrated Review Group; AIDS
The following references are on Advertising: A National Survey of Molecular and Cellular Biology Study
display in the Dockets Management Prescribers in Ambulatory Care Section.
Staff (see ADDRESSES) and are available Settings,’’ Journal of Health Date: July 10, 2017.
for viewing by interested persons Communication, 20:1330–1336, 2015. Time: 8:00 a.m. to 6:00 p.m.
between 9 a.m. and 4 p.m., Monday Dated: June 13, 2017. Agenda: To review and evaluate grant
through Friday; they are also available applications.
Anna K. Abram, Place: Residence Inn Bethesda, 7335
electronically at https:// Deputy Commissioner for Policy, Planning, Wisconsin Avenue, Bethesda, MD 20814.
www.regulations.gov. FDA has verified Legislation, and Analysis. Contact Person: Kenneth A. Roebuck,
the Web site addresses, as of the date [FR Doc. 2017–12599 Filed 6–16–17; 8:45 am] Ph.D., Scientific Review Officer, Center for
this document publishes in the Federal Scientific Review, National Institutes of
BILLING CODE 4164–01–P
Register, but Web sites are subject to Health, 6701 Rockledge Drive, Room 5214,
change over time. MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
1. Johar, K., ‘‘An Insider’s Perspective: DEPARTMENT OF HEALTH AND
Defense of the Pharmaceutical Industry’s HUMAN SERVICES Name of Committee: Center for Scientific
Marketing Practices,’’ Albany Law Review Special Emphasis Panel; AIDS and
Review, 76:299–334, 2012–2013. National Institutes of Health Related Research Member Conflict.
2. Wick, C., M. Egger, S. Trelle, et al., ‘‘The Date: July 10, 2017.
Characteristics of Unsolicited Clinical Center for Scientific Review; Notice of Time: 10:00 a.m. to 5:00 p.m.
Oncology Literature Provided by Agenda: To review and evaluate grant
Closed Meetings applications.
Pharmaceutical Industry,’’ Annals of
Oncology, 18:1580–1582, 2007. Pursuant to section 10(d) of the Place: National Institutes of Health, 6701
3. Fisher, J.A., M.D. Cottingham, and C.A. Federal Advisory Committee Act, as Rockledge Drive, Bethesda, MD 20892
Kalbaugh, ‘‘Peering Into the (Virtual Meeting).
amended (5 U.S.C. App.), notice is
Pharmaceutical ‘Pipeline’: Contact Person: Shalanda A. Bynum,
hereby given of the following meetings. Ph.D., MPH, Scientific Review Officer, Center
Investigational Drugs, Clinical Trials, The meetings will be closed to the
and Industry Priorities,’’ Social Science for Scientific Review, National Institutes of
public in accordance with the Health, 6701 Rockledge Drive, Room 3206,
& Medicine, 131:322–330, 2015.
provisions set forth in sections Bethesda, MD 20892, 301–755–4355,
4. Centerwatch, ‘‘FDA Approved Drugs for
Oncology,’’ https:// 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., bynumsa@csr.nih.gov.
www.centerwatch.com/drug- as amended. The grant applications and Name of Committee: Center for Scientific
information/fda-approved-drugs/ the discussions could disclose Review Special Emphasis Panel; PAR 16–
therapeutic-area/12/oncology (accessed confidential trade secrets or commercial 257: Predicting Behavioral Responses to
on March 2, 2017). property such as patentable material, Population Level Cancer Control Strategies
5. Pazdur, R., ‘‘Endpoints for Assessing Drug and personal information concerning (R21).
Activity in Clinical Trials,’’ The Date: July 11, 2017.
individuals associated with the grant
Oncologist, 13:19–21, 2008. Time: 11:00 a.m. to 2:00 p.m.
applications, the disclosure of which Agenda: To review and evaluate grant
6. Dodge, T. and A. Kaufman, ‘‘What Makes
would constitute a clearly unwarranted applications.
Consumers Think Dietary Supplements
Are Safe and Effective? The Role of invasion of personal privacy. Place: National Institutes of Health, 6701
Disclaimers and FDA Approval,’’ Health Name of Committee: Center for Scientific Rockledge Drive, Bethesda, MD 20892
Psychology, 26:513–517, 2007. Review Special Emphasis Panel; RFA Panel: (Telephone Conference Call).
7. Dodge, T., D. Litt, and A. Kaufman, Revision Applications for U.S.-South Africa Contact Person: Karin F. Helmers, Ph.D.,
‘‘Influence of the Dietary Supplement Program for Collaborative Biomedical Scientific Review Officer, Center for
Health and Education Act on Consumer Research. Scientific Review, National Institutes of
Beliefs About the Safety and Date: June 29, 2017. Health, 6701 Rockledge Drive, Room 3148,
Effectiveness of Dietary Supplements,’’ Time: 2:00 p.m. to 5:00 p.m. MSC 7770, Bethesda, MD 20892, (301) 254–
Journal of Health Communication, Agenda: To review and evaluate grant 9975, helmersk@csr.nih.gov.
16:230–244, 2011. applications. Name of Committee: Center for Scientific
8. Mason, M.J., D.L. Scammon, and X. Fang, Place: National Institutes of Health, 6701 Review Special Emphasis Panel; PAR 15–
‘‘The Impact of Warnings, Disclaimers, Rockledge Drive, Bethesda, MD 20892 287: Opportunities for Collaborative Research
and Product Experience on Consumers’ (Telephone Conference Call). at the NIH Clinical Center.
Contact Person: Robert Freund, Ph.D., Date: July 11, 2017.
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Perceptions of Dietary Supplements,’’
The Journal of Consumer Affairs, 41:74– Scientific Review Officer, Center for Time: 1:30 p.m. to 5:00 p.m.
99, 2007. Scientific Review, National Institutes of Agenda: To review and evaluate grant
9. France, K.R. and P.F. Bone, ‘‘Policy Health, 6701 Rockledge Drive, Room 5216, applications.
Makers’ Paradigms and Evidence From MSC 7852, Bethesda, MD 20892, 301–435– Place: National Institutes of Health, 6701
Consumer Interpretations of Dietary 1050, freundr@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892
Supplement Labels,’’ The Journal of This notice is being published less than 15 (Virtual Meeting).
Consumer Affairs, 39:27–51, 2005. days prior to the meeting due to the timing Contact Person: Fungai Chanetsa, MPH,
10. O’Donoghue, A.C., V. Boudewyns, K.J. limitations imposed by the review and Ph.D., Scientific Review Officer, Center for
Aikin, et al., ‘‘Awareness of the Food and funding cycle. Scientific Review, National Institutes of
VerDate Sep<11>2014 17:09 Jun 16, 2017 Jkt 241001 PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM 19JNN1](https://thefederalregister.org/doc/82_FR_27964/page/1.svg)
![Federal Register / Vol. 82, No. 116 / Monday, June 19, 2017 / Notices 27849
Health, 6701 Rockledge Drive, Room 3135, Place: National Institutes of Health, 6701 DEPARTMENT OF HEALTH AND
MSC 7770, Bethesda, MD 20892, 301–408– Rockledge Drive, Bethesda, MD 20892 HUMAN SERVICES
9436, fungai.chanetsa@nih.hhs.gov. (Virtual Meeting).
Name of Committee: Center for Scientific Contact Person: Michael Eissenstat, Ph.D., National Institutes of Health
Review Special Emphasis Panel; Small Scientific Review Officer, BCMB IRG, Center
Business: Digestive Sciences. for Scientific Review, National Institutes of National Institute of Environmental
Date: July 12, 2017. Health, 6701 Rockledge Drive, Room 4166, Health Sciences; Amended Notice of
Time: 8:00 a.m. to 7:00 p.m. Meeting
Bethesda, MD 20892, 301–435–1722,
Agenda: To review and evaluate grant
applications. eissenstatma@csr.nih.gov.
Notice is hereby given of a change in
Place: Embassy Suites at the Chevy Chase Name of Committee: Center for Scientific the meeting of the National Institute of
Pavilion, 4300 Military Road NW., Review Special Emphasis Panel; Member
Environmental Health Sciences Special
Washington, DC 20015. Conflict: Molecular Genetics.
Contact Person: Martha Garcia, Ph.D., Emphasis Panel, June 06, 2017, 08:00
Date: July 12, 2017.
Scientific Reviewer Officer, Center for a.m. to June 06, 2017, 06:00 p.m.,
Time: 1:00 p.m. to 3:00 p.m.
Scientific Review, National Institutes of NIEHS/National Institute of
Agenda: To review and evaluate grant
Health, 6701 Rockledge Drive, Room 2186, Environmental Health, Keystone
applications.
MSC 7818, Bethesda, MD 20892, 301–435– Building, 530 Davis Drive, Research
1243, garciamc@nih.gov. Place: National Institutes of Health, 6701
Triangle Park, NC 27709 which was
Rockledge Drive, Bethesda, MD 20892
Name of Committee: AIDS and Related published in the Federal Register on
Research Integrated Review Group; AIDS (Telephone Conference Call).
Contact Person: Methode Bacanamwo,
May 26, 2017, 82 FR 24363.
Immunology and Pathogenesis Study This meeting is being amended to
Section. Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of change the date from Tuesday, June 6,
Date: July 12, 2017.
Time: 8:00 a.m. to 5:00 p.m. Health, 6701 Rockledge Drive, Room 2200, 2017 to Thursday, July 6, 2017, 10:00
Agenda: To review and evaluate grant Bethesda, MD 20892, 301–827–7088, a.m. to 10:00 p.m. The meeting is closed
applications. methode.bacanamwo@nih.gov. to the public.
Place: Courtyard Long Beach, 500 East Dated: June 13, 2017.
Name of Committee: Center for Scientific
First Street, Long Beach, CA 90802.
Review Special Emphasis Panel; PAR–16– Natasha M. Copeland,
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for 390: NIBIB Trailblazer Award for New and Program Analyst, Office of Federal Advisory
Scientific Review, National Institutes of Early Stage Investigators (R21). Committee Policy.
Health, 6701 Rockledge Drive, Room 5220, Date: July 12–13, 2017. [FR Doc. 2017–12616 Filed 6–16–17; 8:45 am]
MSC 7852, Bethesda, MD 20892, 301–443– Time: 12:00 p.m. to 4:00 p.m. BILLING CODE 4140–01–P
5779, prasads@csr.nih.gov. Agenda: To review and evaluate grant
Name of Committee: Center for Scientific applications.
Review Special Emphasis Panel; Member Place: National Institutes of Health, 6701 DEPARTMENT OF HEALTH AND
Conflict: Biological Chemistry and Rockledge Drive, Bethesda, MD 20892 HUMAN SERVICES
Macromolecular Biophysics. (Virtual Meeting).
Date: July 12–13, 2017. Contact Person: Chee Lim, Ph.D., Center National Institutes of Health
Time: 8:00 a.m. to 6:00 p.m. for Scientific Review, National Institutes of
Agenda: To review and evaluate grant Health, 6701 Rockledge Drive Room 4128, National Institute of Diabetes and
applications. Bethesda, MD 20892, 301–435–1850, limc4@ Digestive and Kidney Diseases; Notice
Place: National Institutes of Health, 6701
csr.nih.gov. of Closed Meetings
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting). Name of Committee: Center for Scientific Pursuant to section 10(d) of the
Contact Person: Sergei Ruvinov, Ph.D., Review Special Emphasis Panel; Radiation
Federal Advisory Committee Act, as
Scientific Review Officer, Center for Therapy and Biology.
amended (5 U.S.C. App.), notice is
Scientific Review, National Institutes of Date: July 13–14, 2017.
Health, 6701 Rockledge Drive, Room 4158, hereby given of the following meetings.
Time: 9:00 a.m. to 11:00 p.m.
MSC 7806, Bethesda, MD 20892, 301–435– The meetings will be closed to the
Agenda: To review and evaluate grant
1180, ruvinser@csr.nih.gov. applications.
public in accordance with the
Name of Committee: Center for Scientific Place: National Institutes of Health, 6701 provisions set forth in sections
Review Special Emphasis Panel; Urology and Rockledge Drive, Bethesda, MD 20892 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Urogynecology Small Business Applications. (Virtual Meeting). as amended. The grant applications and
Date: July 12, 2017. Contact Person: Bo Hong, Ph.D., Scientific the discussions could disclose
Time: 9:00 a.m. to 1:00 p.m. Review Officer, Center for Scientific Review, confidential trade secrets or commercial
Agenda: To review and evaluate grant property such as patentable material,
National Institutes of Health, 6701 Rockledge
applications. and personal information concerning
Place: National Institutes of Health, 6701 Drive, Room 6194, MSC 7804, Bethesda, MD
20892, 301–996–6208, hongb@csr.nih.gov. individuals associated with the grant
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call). applications, the disclosure of which
(Catalogue of Federal Domestic Assistance
Contact Person: Ganesan Ramesh, Ph.D., would constitute a clearly unwarranted
Program Nos. 93.306, Comparative Medicine;
Center for Scientific Review, National invasion of personal privacy.
93.333, Clinical Research, 93.306, 93.333,
Institutes of Health, 6701 Rockledge Dr., 93.337, 93.393–93.396, 93.837–93.844, Name of Committee: National Institute of
Room 2182, MSC 7818, Bethesda, MD 20892,
asabaliauskas on DSKBBXCHB2PROD with NOTICES
93.846–93.878, 93.892, 93.893, National Diabetes and Digestive and Kidney Diseases
301–827–5467, ganesan.ramesh@nih.gov. Special Emphasis Panel; APOL1 Long-term
Institutes of Health, HHS)
Name of Committee: Center for Scientific Kidney Transplantation Outcomes Network.
Review Special Emphasis Panel; PAR Panel: Dated: June 13, 2017. Date: July 10–11, 2017.
Chemical Discovery for Substance Use Natasha M. Copeland, Time: 8:00 a.m. to 1:30 p.m.
Disorders. Agenda: To review and evaluate
Program Analyst, Office of Federal Advisory
Date: July 12, 2017. cooperative agreement applications.
Committee Policy.
Time: 11:00 a.m. to 5:00 p.m. Place: Embassy Suites at the Chevy Chase
Agenda: To review and evaluate grant [FR Doc. 2017–12591 Filed 6–16–17; 8:45 am] Pavilion, 4300 Military Road NW.,
applications. BILLING CODE 4140–01–P Washington, DC 20015.
VerDate Sep<11>2014 17:09 Jun 16, 2017 Jkt 241001 PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM 19JNN1](https://thefederalregister.org/doc/82_FR_27964/page/2.svg)
Document Created: 2017-06-17 01:47:52
Document Modified: 2017-06-17 01:47:52
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | June 29, 2017. | |
| FR Citation | 82 FR 27848 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR